UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~June~~September 2025

Commission File Number: 001-42669

PITANIUM LIMITED

(Registrant’s Name)

30F, Gravity, 29 Hing Yip Street,

Kwun Tong, Kowloon, Hong Kong

(Address of ~~Principal~~principal ~~Executive~~executive ~~Offices~~offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~On June 13, 2025, Pitanium~~Information ~~Limited~~Contained ~~(the~~in ~~“Company”)~~this closed on the underwriter’s partial exercise of their over-allotment option (the “Over-Allotment Option”) to purchase 90,000 ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), pursuant to the previously disclosed underwriting agreement, dated May 29, 2025 (the “Underwriting Agreement”) with Cathay Securities, Inc., as the representative of the several Underwriters named the Underwriting Agreement (the “Representative”), relating to the Company’s initial public offering pursuant to the Company’s Registration Statement on Form F6-1K (File No. 333-284998) (the “IPO”) of 1,750,000 Ordinary Shares. On June 2, 2025, the Company closed the IPO, and the Representative, concurrently, partially exercised its Over-Allotment Option—172,500 Ordinary Shares. Report

~~Pursuant to the Over-Allotment~~Pitanium ~~Option,~~Limited ~~the~~(“Pitanium”) ~~Representative~~and ~~purchased~~its ansubsidiary ~~additional 90~~(collectively,~~000~~ ~~Ordinary Shares at~~ the ~~public~~“Company”) ~~offering~~is ~~price~~furnishing ofthis ~~$4.00~~Form ~~per share, resulting in additional gross proceeds of $360,000. After giving effect to the exercise of the Over~~6-~~Allotment~~K ~~Option, the total number of Ordinary Shares sold by the Company in the IPO increased~~ to ~~2,012,500 ordinary shares and the gross proceeds increased to $8.05 million, before~~provide ~~deducting~~six-month ~~underwriting~~interim ~~discounts~~financial ~~and other related expenses~~statements.

~~This report does not constitute~~Special anNote ~~offer~~Regarding toForward-Looking sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.Statements

Statements in this current report with respect to the Company’s current plans, estimates, strategies, beliefs and other statements that are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include, but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,” “prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or “should,” and words of similar meaning in connection with a discussion of future operations, financial performance, events, or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management’s assumptions, judgments, and beliefs in light of the information currently available to it. The Company cautions investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking statements, including but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ significantly from those set forth in the forward-looking statements.

All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Financial Statements and Exhibits.

Exhibits:

Exhibit No.		Description
99.1		Unaudited Interim Consolidated Financial Statements as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024
99.2		Operating and Financial Review in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended March 31, 2025 and 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		PITANIUM LIMITED
Date: September 15, 2025	Pitanium Limited
Date:	June 16, 2025	By:	/s/ Ying Yeung Wong
	By:	/s/ Ying Yeung Wong
	Name:	~~Name:~~Ying Yeung Wong	~~Ying Yeung Wong~~
	Title:	~~Title:~~Chief Executive Officer and Director	~~Chief Executive Officer and Director~~

Filing Compare · Pitanium Ltd